ADPT logo

Adaptive Biotechnologies (ADPT)

Profile

Full Name

Adaptive Biotechnologies Corporation

Ticker Symbol

ADPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 27, 2019

Indexes

Not included

Website

http://www.adaptivebiotech.com

Employees

619

Key Details

Price

$7.74(-1.02%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$178.96M(+5.10% YoY)

Annual EPS

-$1.08(+30.77% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.74
ADPT price is $7.74

30-Day Relative Volume

0.61
ADPT 30-day relative volume is 0.61

Price Performance

Price Most recent change

-1.02%
ADPT price was down -1.02% on Apr 15, 2025

Price YTD change

+29.11%
ADPT price is up +29.11% since January 1st

Price 1-year change

+165.98%
ADPT price is up +165.98% year-on-year

Price 3-year change

-28.47%
ADPT price is down -28.47% over the past 3 years

Price Range

Price All-time high

$71.25
ADPT price is currently -89.14% below its historical high of $71.25

Price 3-year low

$2.28
ADPT price is currently +239.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.15B
ADPT market capitalization is $1.15 billion

Market cap 3-year change

-25.27%
ADPT market capitalization is down -25.27% over the past 3 years

Market cap All-time high

$9.32B
ADPT market capitalization is currently -87.67% below its historical high of $9.32 billion

Market cap sector rank

78.04%
ADPT market capitalization is higher than 78.04% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.82%
ADPT shares outstanding is up +0.82% year-on-year

Shares Outstanding 3-Year Change

+4.47%
ADPT shares outstanding is up +4.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.54
ADPT beta is 1.54

200-day SMA

$5.91
ADPT price is currently +30.99% above its 200-day simple moving average

50-day SMA

$7.88
ADPT price is currently -1.82% below its 50-day simple moving average

RSI

49.11
ADPT 14-day relative strength index is 49.11

Volume

0.61
ADPT 30-day relative volume is 0.61

ATR

$0.76
ADPT average true range is $0.76

10-day Historical Volatility

82.70%
ADPT 10-day historical volatility is 82.70%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$178.96M
ADPT annual revenue is $178.96 million

Revenue Analysts estimate

$212.69M
ADPT annual revenue is currently -15.86% lower than the consensus analysts' forecast

Revenue 1-year change

+5.1%
ADPT annual revenue is up +5.1% year-on-year

Revenue Sector rank

62.12%
ADPT annual revenue is higher than 62.12% of companies in Healthcare sector

EPS

EPS

-$1.08
ADPT annual earnings per share is -$1.08

EPS Analysts estimate

-$0.91
ADPT annual earnings per share is currently +18.25% higher than the consensus analysts' forecast

EPS 1-year change

+30.77%
ADPT annual earnings per share is up +30.77% year-on-year

EPS Sector rank

54.85%
ADPT annual earnings per share is higher than 54.85% of companies in Healthcare sector

Profit

Gross profit

$106.88M
ADPT annual gross profit is $106.88 million

Gross margin

59.72%
ADPT annual gross profit margin is 59.72%

Operating profit

-$155.34M
ADPT annual operating income is -$155.34 million

Operating margin

-86.81%
ADPT annual operating profit margin is -86.81%

Net income

-$159.49M
ADPT annual net profit is -$159.49 million

Net margin

-89.12%
ADPT annual net profit margin is -89.12%

Expenses

Total expenses

$334.30M
ADPT annual total expenses is $334.30 million

Operating expenses

$262.22M
ADPT annual total operating expenses is $262.22 million

Cost of goods sold

$72.08M
ADPT annual cost of goods sold is $72.08 million

Selling, general & administrative expenses

$157.56M
ADPT annual SGA is $157.56 million

Depreciation and amortization

$19.26M
ADPT annual depreciation & amortization is $19.26 million

Interest expense

$11.58M
ADPT annual interest expense is $11.58 million

Income tax

-
ADPT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$148.01M
ADPT annual earnings before interest & taxes is -$148.01 million

EBITDA

-$146.31M
ADPT annual EBITDA is -$146.31 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$539.38M
ADPT annual total assets is $539.38 million

Non current assets

$255.62M
ADPT annual long term assets is $255.62 million

Current assets

$283.75M
ADPT annual total current assets is $283.75 million

Cash and cash equivalents

$47.92M
ADPT annual cash & cash equivalents is $47.92 million

Accounts receivable

$41.73M
ADPT annual accounts receivable is $41.73 million

Inventory

$8.44M
ADPT annual inventory is $8.44 million

Liabilities

Total liabilities

$336.89M
ADPT annual total liabilities is $336.89 million

Long term liabilities

$238.84M
ADPT annual total long term liabilities is $238.84 million

Current liabilities

$98.05M
ADPT annual total current liabilities is $98.05 million

Accounts payable

$7.26M
ADPT annual accounts payable is $7.26 million

Debt

Total debt

$89.39M
ADPT annual total debt is $89.39 million

Total debt 1-year change

-9.5%
ADPT annual total debt is down -9.5% year-on-year

Long term debt

$79.15M
ADPT annual long term debt is $79.15 million

Short term debt

$10.24M
ADPT annual short term debt is $10.24 million

Equity & Capital

Shareholders equity

$202.71M
ADPT annual stockholders equity is $202.71 million

Book value

$202.71M
ADPT annual book value is $202.71 million

Retained earnings

-$1.30B
ADPT annual retained earnings is -$1.30 billion

Working capital

$185.70M
ADPT annual working capital is $185.70 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$95.21M
ADPT annual cash flow from operations is -$95.21 million

Cash from operations 1-year change

+39.09%
ADPT annual cash flow from operations is up +39.09% year-on-year

Cash from investing

$77.79M
ADPT annual cash flow from investing activities is $77.79 million

Cash from investing 1-year change

-40%
ADPT annual cash flow from investing activities is down -40% year-on-year

Cash from financing

$241.00K
ADPT annual cash flow from financing activities is $241.00 thousand

Cash from financing 1-year change

-89.27%
ADPT annual cash flow from financing activities is down -89.27% year-on-year

CAPEX

CAPEX

$3.66M
ADPT annual capital expenditures is $3.66 million

CAPEX 1-year change

-65.75%
ADPT annual capital expenditures is down -65.75% year-on-year

Free Cash Flow

Free cash flow

-$98.88M
ADPT annual free cash flow is -$98.88 million

Free cash flow 1-year change

+40.8%
ADPT annual free cash flow is up +40.8% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

59.72%
ADPT annual gross profit margin is 59.72%

Operating margin

-86.81%
ADPT annual operating profit margin is -86.81%

Net margin

-89.12%
ADPT annual net profit margin is -89.12%

ROA & ROE

ROA

-26.57%
ADPT annual return on assets is -26.57%

ROE

-62.45%
ADPT annual return on equity is -62.45%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ADPT price to earnings ratio value is unknown

PE ratio Sector rank

-
ADPT price to earnings ratio is unknown

PB Ratio

PB ratio

5.67
ADPT price to book ratio is 5.67

PB ratio Sector rank

84.94%
ADPT price to book ratio is higher than 84.94% of companies in Healthcare sector

PS Ratio

PS ratio

6.43
ADPT price to sales ratio is 6.43

PS ratio Sector rank

71.41%
ADPT price to sales ratio is higher than 71.41% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.19B
ADPT enterprise value is $1.19 billion

Enterprise value Sector rank

76.59%
ADPT enterprise value is higher than 76.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-8.97
ADPT EV/EBITDA is -8.97

EV/EBITDA Sector rank

12.01%
ADPT EV/EBITDA is higher than 12.01% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.89
ADPT annual current ratio is 2.89

Quick ratio

2.81
ADPT annual quick ratio is 2.81

Leverage

Debt to equity

0.00
ADPT annual debt to equity ratio is 0.00

Interest coverage ratio

-12.78
ADPT annual interest coverage ratio is -12.78

Risk & Stability

Piotroski F-Score

4
ADPT piotroski f-score is 4

Altman Z-Score

-1.50
ADPT altman z-score is -1.50

Analyst ratings

Recent major analysts updates

Mar 21, 25 Goldman Sachs
Buy
Feb 20, 25 Piper Sandler
Overweight
Feb 13, 25 Scotiabank
Sector Outperform
Jan 28, 25 Goldman Sachs
Neutral
Dec 18, 24 BTIG
Buy
Nov 11, 24 Piper Sandler
Overweight
Oct 2, 24 BTIG
Buy
Aug 2, 24 JP Morgan
Overweight
May 8, 24 JP Morgan
Overweight
Apr 4, 24 BTIG
Buy

Institutional Ownership

Similar stocks

Kestra Medical Technologies (KMTS)
PCRX logo
Pacira BioSciences (PCRX)
PLSE logo
Pulse Biosciences (PLSE)
MD logo
Pediatrix Medical (MD)
LQDA logo
Liquidia (LQDA)
Indivior (INDV)
INVA logo
Innoviva (INVA)
TNDM logo
Tandem Diabetes Care (TNDM)
AMPH logo
Amphastar Pharmaceuticals (AMPH)
  • What is the ticker symbol for Adaptive Biotechnologies?
  • Does Adaptive Biotechnologies pay dividends?
  • What sector is Adaptive Biotechnologies in?
  • What industry is Adaptive Biotechnologies in?
  • What country is Adaptive Biotechnologies based in?
  • When did Adaptive Biotechnologies go public?
  • Is Adaptive Biotechnologies in the S&P 500?
  • Is Adaptive Biotechnologies in the NASDAQ 100?
  • Is Adaptive Biotechnologies in the Dow Jones?
  • When was Adaptive Biotechnologies's last earnings report?
  • When does Adaptive Biotechnologies report earnings?
  • Should I buy Adaptive Biotechnologies stock now?

What is the ticker symbol for Adaptive Biotechnologies?

The ticker symbol for Adaptive Biotechnologies is NASDAQ:ADPT

Does Adaptive Biotechnologies pay dividends?

No, Adaptive Biotechnologies does not pay dividends

What sector is Adaptive Biotechnologies in?

Adaptive Biotechnologies is in the Healthcare sector

What industry is Adaptive Biotechnologies in?

Adaptive Biotechnologies is in the Biotechnology industry

What country is Adaptive Biotechnologies based in?

Adaptive Biotechnologies is headquartered in United States

When did Adaptive Biotechnologies go public?

Adaptive Biotechnologies's initial public offering (IPO) was on June 27, 2019

Is Adaptive Biotechnologies in the S&P 500?

No, Adaptive Biotechnologies is not included in the S&P 500 index

Is Adaptive Biotechnologies in the NASDAQ 100?

No, Adaptive Biotechnologies is not included in the NASDAQ 100 index

Is Adaptive Biotechnologies in the Dow Jones?

No, Adaptive Biotechnologies is not included in the Dow Jones index

When was Adaptive Biotechnologies's last earnings report?

Adaptive Biotechnologies's most recent earnings report was on Feb 11, 2025

When does Adaptive Biotechnologies report earnings?

The next expected earnings date for Adaptive Biotechnologies is May 1, 2025

Should I buy Adaptive Biotechnologies stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page